Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Assess the Efficacy and Safety of CEP-1347 in Patients With Parkinson's Disease

NCT00040404 is registered in ClinicalTrials.gov with Cephalon as lead sponsor.

NCT NCT00040404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00040404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Assess the Efficacy and Safety of CEP-1347 in Patients With Parkinson's Disease
Lead sponsor
Cephalon
Phase
Phase 2/3
Overall status
Terminated
Start date
March 31, 2002
Completion date
August 31, 2005
Enrollment
806 (actual)
Sites
66

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease